Katrien Janssen

Etravirine Has No Effect on QT and Corrected QT Interval in HIV-Negative Volunteers

M. Peeters, M. Schöller-Gyüre, T. Kakuda, 2008, The Annals of pharmacotherapy.

Incidence of virological failure and emergence of resistance with twice‐daily vs every 8‐h administration of telaprevir in the OPTIMIZE study

M. Buti, G. Picchio, I. Dierynck, 2014, Journal of viral hepatitis.

Clinical and virological predictors of sustained response with an interferon-based simeprevir regimen for patients with chronic genotype 1 hepatitis C virus infection.

G. D'offizi, M. Schlag, C. Taibi, 2017, The new microbiologica.

Virology analyses of HCV genotype 4 isolates from patients treated with simeprevir and peginterferon/ribavirin in the Phase III RESTORE study

M. Peeters, O. Lenz, T. Verbinnen, 2017, Journal of viral hepatitis.

Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN study

X. Forns, M. Durlik, J. Calleja, 2017, Transplant infectious disease : an official journal of the Transplantation Society.